Literature DB >> 8395285

Excitatory amino acid receptor-stimulated phosphoinositide turnover in primary cerebrocortical cultures.

G J Birrell1, F W Marcoux.   

Abstract

1. Characterization of excitatory amino acid-induced accumulation of [3H]-phosphoinositides was carried out in primary cerebrocortical cultures isolated from foetal rats. 2. All of the excitatory amino acid receptor agonists examined caused concentration-dependent enhancement of phosphoinositide (PI) formation. The most potent excitatory amino acid receptor agonists were quisqualate, (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid ((1S,3R)-ACPD), ibotenate and glutamate with mean EC50 values of 0.9 +/- 0.4 microM, 15 +/- 5 microM, 15 +/- 3 microM and 41 +/- 8 microM respectively. 3. The selective ionotropic receptor antagonists kynurenic acid (1 mM), 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(F)quinoxaline (NBQX, 10 microM) and (+/-)-4-(3-phosphonopropyl)-2 piperazinecarboxylic acid (CPP, 100 microM), failed to block responses to quisqualate, (1S,3R)-ACPD or glutamate. D,L-2-Amino-3-phosphonopropionate (D,L-AP3) did not block 1S,3R-ACPD or quisqualate-induced PI turnover, but had an additive effect with quisqualate or (1S,3R)-ACPD. 4. Exposure of cultures to agonists in the absence of added extracellular calcium reduced the maximal quisqualate response by approximately 45%, revealing a two-component concentration-response curve. Concentration-response curves to ibotenate and glutamate became flattened by omission of extracellular calcium, whereas (1S,3R)-ACPD-stimulated PI turnover was unaffected. 5. Pretreatment of cultures with pertussis toxin markedly inhibited PI responses evoked by (1S,3R)-ACPD. 6. These results suggest that excitatory amino acid-stimulated PI turnover in cerebrocortical cultures is independent of ionotropic receptor activation and is mediated via specific G-protein-linked metabotropic receptors. The partial dependence of the responses to quisqualate, ibotenate and glutamate on the presence of extracellular calcium suggests that the effects of these agonists may be mediated by more than one receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395285      PMCID: PMC2175676          DOI: 10.1111/j.1476-5381.1993.tb13580.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  49 in total

1.  Characterization of subtypes of excitatory amino acid receptors involved in the stimulation of inositol phosphate synthesis in rat brain synaptoneurosomes.

Authors:  M Récasens; I Sassetti; A Nourigat; F Sladeczek; J Bockaert
Journal:  Eur J Pharmacol       Date:  1987-09-02       Impact factor: 4.432

2.  (2S,3S,4S) alpha-(carboxycyclopropyl)glycine is a novel agonist of metabotropic glutamate receptors.

Authors:  Y Nakagawa; K Saitoh; T Ishihara; M Ishida; H Shinozaki
Journal:  Eur J Pharmacol       Date:  1990-08-02       Impact factor: 4.432

3.  Glutamate receptors and phosphoinositide metabolism: stimulation via quisqualate receptors is inhibited by N-methyl-D-aspartate receptor activation.

Authors:  E Palmer; D T Monaghan; C W Cotman
Journal:  Brain Res       Date:  1988-09       Impact factor: 3.252

4.  Stimulatory and inhibitory actions of excitatory amino acids on inositol phospholipid metabolism in rat cerebral cortex.

Authors:  P P Godfrey; C J Wilkins; W Tyler; S P Watson
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

5.  The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells.

Authors:  F Nicoletti; J T Wroblewski; A Novelli; H Alho; A Guidotti; E Costa
Journal:  J Neurosci       Date:  1986-07       Impact factor: 6.167

6.  Pertussis toxin inhibits signal transduction at a specific metabolotropic glutamate receptor in primary cultures of cerebellar granule cells.

Authors:  F Nicoletti; J T Wroblewski; E Fadda; E Costa
Journal:  Neuropharmacology       Date:  1988-06       Impact factor: 5.250

7.  Excitatory amino acids inhibit stimulated phosphoinositide hydrolysis in the rat prefrontal cortex.

Authors:  E P Noble; E Sincini; D Bergmann; G ten Bruggencate
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

8.  A new type of glutamate receptor linked to inositol phospholipid metabolism.

Authors:  H Sugiyama; I Ito; C Hirono
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

9.  Excitatory amino acid agonist-antagonist interactions at 2-amino-4-phosphonobutyric acid-sensitive quisqualate receptors coupled to phosphoinositide hydrolysis in slices of rat hippocampus.

Authors:  D D Schoepp; B G Johnson
Journal:  J Neurochem       Date:  1988-05       Impact factor: 5.372

10.  Dual action of excitatory amino acids on the metabolism of inositol phosphates in striatal neurons.

Authors:  B H Schmidt; S Weiss; M Sebben; D E Kemp; J Bockaert; F Sladeczek
Journal:  Mol Pharmacol       Date:  1987-09       Impact factor: 4.436

View more
  4 in total

1.  Action of 5-hydroxytryptamine in facilitating N-methyl-D-aspartate depolarization of cortical neurones mimicked by calcimycin, cyclopiazonic acid and thapsigargin.

Authors:  S Rahman; R S Neuman
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Stimulatory effects of the putative metabotropic glutamate receptor antagonist L-AP3 on phosphoinositide turnover in neonatal rat cerebral cortex.

Authors:  R Mistry; G Prabhu; M Godwin; R A Challiss
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Characterization of metabotropic glutamate receptor-mediated facilitation of N-methyl-D-aspartate depolarization of neocortical neurones.

Authors:  S Rahman; R S Neuman
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

4.  Modulatory effects of NMDA on phosphoinositide responses evoked by the metabotropic glutamate receptor agonist 1S,3R-ACPD in neonatal rat cerebral cortex.

Authors:  R A Challiss; R Mistry; D W Gray; S R Nahorski
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.